Suppr超能文献

环磷酸鸟苷和细胞外钙离子在大鼠肝细胞糖原分解调节中的作用研究。

Studies on the role of cyclic guanosine 3':5'-monophosphate and extracellular Ca2+ in the regulation of glycogenolysis in rat liver cells.

作者信息

Pointer R H, Butcher F R, Fain J N

出版信息

J Biol Chem. 1976 May 25;251(10):2987-92.

PMID:178660
Abstract

Catecholamines increased guanosine 3':5'-monophosphate (cyclic GMP) accumulation by isolated rat liver cells. The increases in cyclic GMP due to 1.5 muM epinephrine, isoproterenol, or phenylephrine were blocked by phenoxybenzamine but not by propranolol. The possibility that cyclic GMP is involved in the glycogenolytic action of catecholamines seems unlikely since cyclic GMP accumulation is also elevated by carbachol, insulin, A23187, and to a lesser extent by glucagon. Furthermore, carbachol had little effect on glycogenolysis while insulin actually inhibited hepatic glycogenolysis. The rise in cyclic GMP due to carbachol was abolished by atropine and that due to all agents was markedly reduced by the omission of extracellular calcium. However, the glycogenolytic action of glucagon and catecholamines was only slightly inhibited by the omission of calcium. The only agent which was unable to stimulate glycogenolysis in calcium-free buffer was the divalent cation ionophore A23187. There was a drop in ATP content of liver cells during incubation in calcium-free buffer which was accompanied by an inhibition of glucagon-activated adenosine 3':5'-monophosphate (cyclic AMP) accumulation. The presence of calcium inhibited the rise in adenylate cyclase activity of lysed rat liver cells due to glucagon or isoproterenol but not that due to fluoride. These results suggest that the stimulation by catecholamines and glucagon of glycogenolysis is not mediated through cyclic GMP nor does it depend on the presence of extracellular calcium. Cyclic GMP accumulation was increased in liver cells by agents which either inhibit, have little affect, or accelerate glycogenolysis. The significance of elevations of cyclic GMP in rat liver cells remains to be established.

摘要

儿茶酚胺可增加离体大鼠肝细胞中鸟苷 3':5'-单磷酸(环磷酸鸟苷,cGMP)的积累。1.5 μM 肾上腺素、异丙肾上腺素或去氧肾上腺素引起的 cGMP 增加被酚苄明阻断,但未被普萘洛尔阻断。cGMP 参与儿茶酚胺糖原分解作用的可能性似乎不大,因为卡巴胆碱、胰岛素、A23187 也可使 cGMP 积累增加,胰高血糖素在较小程度上也有此作用。此外,卡巴胆碱对糖原分解作用影响很小,而胰岛素实际上抑制肝糖原分解。阿托品可消除卡巴胆碱引起的 cGMP 升高,而所有药物引起的 cGMP 升高在无细胞外钙时均明显降低。然而,无钙时胰高血糖素和儿茶酚胺的糖原分解作用仅略有抑制。唯一在无钙缓冲液中不能刺激糖原分解的药物是二价阳离子载体 A23187。在无钙缓冲液中孵育期间,肝细胞中的 ATP 含量下降,同时伴有胰高血糖素激活的腺苷 3':5'-单磷酸(环磷酸腺苷,cAMP)积累的抑制。钙的存在抑制了胰高血糖素或异丙肾上腺素引起的裂解大鼠肝细胞腺苷酸环化酶活性升高,但不影响氟化物引起的升高。这些结果表明,儿茶酚胺和胰高血糖素对糖原分解的刺激不是通过 cGMP 介导的,也不依赖于细胞外钙的存在。抑制、几乎无影响或加速糖原分解的药物均可使肝细胞中的 cGMP 积累增加。大鼠肝细胞中 cGMP 升高的意义尚待确定。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验